We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

USAU:NASDAQU.S. Gold Corp. Analysis

Data as of 2026-09-19 - not real-time

$15.41

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind U.S. Gold Corp. is neutral at $15.41, with no clear ordering between short and long averages. The last 30 days have gained 2.5%. With RSI at 50.0 the momentum picture is neutral, alongside a bearish MACD signal. The recent range runs from support at $14.36 up to resistance at $17.26.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 81.4% above where the shares trade now.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 44.2%, a beta of 1.97 and a maximum drawdown of 44.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Near-term and long-term part ways here — sell short-term against hold longer out, with 3/10 conviction on the long call.

Top Market Events

Updated Aug 20, 2026 0 Advancing the Fully Permitted, Shovel Ready CK Gold Project CHEYENNE, Wyo.U.S. Gold Corp. "U.S. Gold," the "Company," "we," "our" or "us" Nasdaq: USAU will present at the Moody Capital...U.S. Gold Corp. "U.S. Gold," the "Company," "we," "our" or "us" Nasdaq: USAU , a U.S.-focused development and gold and...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Trading below the 200-day average of 16.52
  • MACD momentum is negative
  • 30-day volatility of 44.2%

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Trading below the 200-day average of 16.52
  • Analyst targets imply +81.4% versus the current price
  • 30-day volatility of 44.2%

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Analyst targets imply +81.4% versus the current price
  • Negative return on equity of -55.2%
  • Negative free cash flow

Key Metrics & Analysis

Financial Health

P/E Ratio-16.8
ROE-55.24%
ROA-33.60%
Debt/Equity0.18
P/B Ratio5.2
Op. Cash Flow$-18438924
Free Cash Flow$-13006926

Technical Analysis

TrendNeutral
RSI50.0
Support$14.36
Resistance$17.26
MA 20$15.74
MA 50$14.99
MA 200$16.52
MACDBearish
VolumeDecreasing
Fear & Greed Index94.98

Valuation

Target Price$27.95
Upside/Downside81.38%
GradeFair
TypeGrowth

Risk Assessment

Beta1.97
Volatility44.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.